SBIR/STTR Research Award

NUCLEAR TRANSFER IN NON-HUMAN PRIMATES

Award identifier ee012722bedaa0b7d0546271722829c8369e25b6e4d3e59785c9831e4f6d07d4Awarding agency Department of Health and Human Services

Award amount

$49,784

Program and phase

SBIR · Phase I

Award year

1991

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Not reported
Recipient company
Granada Biosciences Inc
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

GRANADA BIOSCIENCES WILL EXPLORE VARIOUS METHODOLOGIC FACTORS PREPARATORY TO CLONING NON-HUMAN PRIMATE EMBRYOS. THE LIMITED AVAILABILITY OF PRIMATES FOR RESEARCH AND THE PROBLEMS OF DISEASE WITHIN COLONIES SUGGEST THAT CLONED NON-HUMAN PRIMATES WOULD HAVE SUBSTANTIAL ADVANTAGES FOR THE RESEARCH COMMUNITY. PRESENTLY, CLONING TECHNIQUES FOR ANUMBER OF COMMON EUTHERIAN MAMMALS HAVE BEEN DEVELOPED. THETECHNIQUES ARE SIMILAR ENOUGH, BETWEEN SPECIES, TO ASSUME THAT THEY CAN BE SUCCESSFULLY APPLIED TO PRIMATES WITH RELATIVELY LITTLE MODIFICATION. WE WILL DETERMINE THE TIMING OF NUCLEAR MATURATION IN VITRO, THE ABILITY OF OOCYTES TO ACTIVATE IN RESPONSE TO AN ELECTRIC STIMULUS, THE MOST EFFECTIVE MEANS OF ENUCLEATING OOCYTES AND THE EXTENT TO WHICH OOCYTES WILL FUSE WITH NON-PRIMATE BLASTOMERES. WE PLAN TO OBTAIN OOCYTES FROM ANIMALS AT REGIONAL PRIMATE FACILITIES THAT ARE BEING SACRIFICED FOR OTHER PURPOSES. THE OOCYTES WILL BE ASPIRATED FROM SECONDARY FOLLICLES AND PLACED IN VARIOUS INCUBATION MEDIA FOR TRANSPORT TO THE OUR LABORATORIES. DURING PHASE II, WE INTEND TO DEMONSTRATE THE EFFICACY OF THE OPTIMIZED TECHNIQUES FROM PHASE I TO CULTURE EMBRYOS. GRANADA BIOSCIENCES WILL EXPLORE VARIOUS METHODOLOGIC FACTORS PREPARATORY TO CLONING NON-HUMAN PRIMATE EMBRYOS. THE LIMITED AVAILABILITY OF PRIMATES FOR RESEARCH AND THE PROBLEMS OF DISEASE WITHIN COLONIES SUGGEST THAT CLONED NON-HUMAN PRIMATES WOULD HAVE SUBSTANTIAL ADVANTAGES FOR THE RESEARCH COMMUNITY. PRESENTLY, CLONING TECHNIQUES FOR ANUMBER OF COMMON EUTHERIAN MAMMALS HAVE BEEN DEVELOPED. THETECHNIQUES ARE SIMILAR ENOUGH, BETWEEN SPECIES, TO ASSUME THAT THEY CAN BE SUCCESSFULLY APPLIED TO PRIMATES WITH RELATIVELY LITTLE MODIFICATION. WE WILL DETERMINE THE TIMING OF NUCLEAR MATURATION IN VITRO, THE ABILITY OF OOCYTES TO ACTIVATE IN RESPONSE TO AN ELECTRIC STIMULUS, THE MOST EFFECTIVE MEANS OF ENUCLEATING OOCYTES AND THE EXTENT TO WHICH OOCYTES WILL FUSE WITH NON-PRIMATE BLASTOMERES. WE PLAN TO OBTAIN OOCYTES FROM ANIMALS AT REGIONAL PRIMATE FACILITIES THAT ARE BEING SACRIFICED FOR OTHER PURPOSES. THE OOCYTES WILL BE ASPIRATED FROM SECONDARY FOLLICLES AND PLACED IN VARIOUS INCUBATION MEDIA FOR TRANSPORT TO THE OUR LABORATORIES. DURING PHASE II, WE INTEND TO DEMONSTRATE THE EFFICACY OF THE OPTIMIZED TECHNIQUES FROM PHASE I TO CULTURE EMBRYOS.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.